TP53 and neoplasm: Among these were interactions involving the tumour suppressors TP53 and SMAD4 in PDAC, which are known genes mutated in the tumour, and the DNA double-strand break (DSB) repair proteins BRE and BRCC3 along with BRCA1, BRCA2 and TP53, in breast tumours.